AI in Drug Discovery Market


AI in Drug Discovery Market – Size, Share, Growth, Trends, and Forecast (2025–2034): Global Industry Analysis by Offering Type (Software, Services), Drug Type (Small Molecules, Biologics, Cell Therapies, Gene Therapies, Monoclonal Antibodies, and Others), Technology (Machine Learning, Natural Language Processing, and Others), Application (Target Identification, Target Validation, Preclinical and Clinical Trial Design, and Others), Therapeutic Area (Oncological Disorders, Infectious Diseases, Neurological Disorders, Metabolic Disorders, Cardiovascular Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Others)

Individual License

US $4,450
  • Accessible by 1 user only
  • 15% or 32 hours of free customization
  • Free post-sale support
  • Direct access to analysts
  • Delivery via Compass cloud platform

Team License

US $5,450
  • Accessible by up to 5 users
  • 25% or 54 hours of customization
  • Access to report summaries
  • Delivery via Compass cloud platform
  • Dedicated account manager
  • Service guarantee & refund coverage
  • Personal brief from the lead author

Enterprise License

US $7,450
  • All team license benefits included
  • 30% or 64 hours customization
  • Unlimited user access (internal)
  • Early access to latest research
  • 30% discount on next purchase
  • Custom dashboards on Compass